Sign in Sign up for free

Adma Biologics Inc Revenue Y/Y

What is the Revenue Y/Y of Adma Biologics Inc?

The Revenue Y/Y of Adma Biologics Inc is 58.69%

What is the definition of Revenue Y/Y?

Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.

= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to Adma Biologics Inc

What does Adma Biologics Inc do?

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.

Companies with revenue y/y similar to Adma Biologics Inc